SeekingAlpha · Aug 14, 2026
Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript
Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call August 14, 2026 8:30 AM EDTCompany ParticipantsEric Hines - CEO, President & DirectorKeisha...
ML
AMEX · MLSS
Milestone Scientific Inc.
Healthcare · Medical - Instruments & Supplies
$0.48
Up+$0.01 (+2.23%)
Updated Aug 23, 2026, 7:49 PM
SID Score
6.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 28.42M
- P/E ratio
- -4.46
- Dividend yield
- 0.00%
- 52-week range
- $0.25 – $0.58
- Volume
- 91.05K
- Avg. volume
- 1.16M
Price performance
MLSS price history
1M range · 20 trading sessions · Daily adjusted prices
MLSS closed at $0.48 after 20 trading sessions, up 19.48% for the selected period.
- Last close
- $0.48
- Period change
- +19.48%
- Period low
- $0.38
- Period high
- $0.55
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $0.48 | $0.49 | $0.47 | $0.4808 | 91.05K |
| Aug 20, 2026 | $0.47 | $0.477 | $0.44 | $0.4703 | 42.88K |
| Aug 19, 2026 | $0.481 | $0.4999 | $0.461 | $0.4701 | 77.54K |
| Aug 18, 2026 | $0.485 | $0.5032 | $0.4612 | $0.493 | 131.71K |
| Aug 17, 2026 | $0.49 | $0.49 | $0.4565 | $0.488 | 423.85K |
| Aug 14, 2026 | $0.4775 | $0.5182 | $0.4501 | $0.4951 | 365.15K |
| Aug 13, 2026 | $0.53 | $0.5796 | $0.5201 | $0.553 | 783.1K |
| Aug 12, 2026 | $0.4813 | $0.54 | $0.48 | $0.5292 | 286.28K |
| Aug 11, 2026 | $0.4775 | $0.495 | $0.475 | $0.4864 | 119.79K |
| Aug 10, 2026 | $0.445 | $0.48 | $0.4401 | $0.475 | 130.82K |
| Aug 7, 2026 | $0.465 | $0.49 | $0.4601 | $0.4811 | 130.81K |
| Aug 6, 2026 | $0.4421 | $0.465 | $0.4421 | $0.465 | 40.43K |
| Aug 5, 2026 | $0.4507 | $0.476 | $0.4492 | $0.4685 | 54.24K |
| Aug 4, 2026 | $0.4517 | $0.4782 | $0.4161 | $0.456 | 243.85K |
| Aug 3, 2026 | $0.40 | $0.47 | $0.40 | $0.4351 | 433.97K |
| Jul 31, 2026 | $0.3733 | $0.403 | $0.37 | $0.399 | 125.35K |
| Jul 30, 2026 | $0.378 | $0.3951 | $0.378 | $0.3911 | 41.48K |
| Jul 29, 2026 | $0.422 | $0.422 | $0.376 | $0.376 | 48.65K |
| Jul 28, 2026 | $0.4024 | $0.4331 | $0.38 | $0.43 | 135.22K |
| Jul 27, 2026 | $0.395 | $0.4162 | $0.3718 | $0.4024 | 145.61K |
Latest MLSS news
The latest Smart Investors Daily articles mentioning MLSS.
Stock researchCompany · Overview
MLSS research
Overview
Company profile and research snapshot.
Company profile
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $4.00
- Implied upside
- —
- Analysts
- 8
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 20, 2025 | Benchmark | Speculative Buy | — |
| Nov 20, 2024 | Benchmark | Speculative Buy | — |
| Oct 10, 2024 | Benchmark | Speculative Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 14, 2026
Conference Call: Milestone Scientific Affirms FY2026 Sales Guidance of $9.800M-$10.200M vs $9.910M Est
Milestone Scientific (AMEX:MLSS) affirms FY2026 sales outlook from $9.800 million-$10.200 million to $9.800 million-$10.200 million vs $9.910 million estimate.
Benzinga · Aug 14, 2026
Conference Call: Milestone Scientific Sees Q3 Sales $2.300M-$2.500M vs $2.510M Est
Milestone Scientific (AMEX:MLSS) sees Q3 sales of $2.300 million-$2.500 million vs $2.510 million analyst estimate.
Benzinga · Aug 14, 2026
Transcript: Milestone Scientific Q2 2026 Earnings Conference Call
Milestone Scientific (AMEX:MLSS) released second-quarter financial results and hosted an earnings call on Friday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
